Listed

BioAtla, Inc.

BCABOTCCIK 1826892HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q3 FY2023
Operating income$227.0k, Q2 FY2026
Net income$452.0k, Q2 FY2026
BioAtla, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2023-11-07, accession 0000950170-23-060389.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m28.4Research and development, Q3 FY2023, three months to 2023-09-30$28.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123506.Report this figure22.7Research and development, Q4 FY2023, three months to 2023-12-31$22.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-28, accession 0000950170-25-046217. Derived: 12-month figure less the 9-month figure.Report this figure18.9Research and development, Q1 FY2024, three months to 2024-03-31$18.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure16.2Research and development, Q2 FY2024, three months to 2024-06-30$16.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105220.Report this figure16.4Research and development, Q3 FY2024, three months to 2024-09-30$16.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure11.7Research and development, Q4 FY2024, three months to 2024-12-31$11.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134499. Derived: 12-month figure less the 9-month figure.Report this figure12.4Research and development, Q1 FY2025, three months to 2025-03-31$12.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure13.7Research and development, Q2 FY2025, three months to 2025-06-30$13.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure9.5Research and development, Q3 FY2025, three months to 2025-09-30$9.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure8.0Research and development, Q4 FY2025, three months to 2025-12-31$8.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134499. Derived: 12-month figure less the 9-month figure.Report this figure4.6Research and development, Q1 FY2026, three months to 2026-03-31$4.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure3.3Research and development, Q2 FY2026, three months to 2026-06-30$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure
Operating income$m(35.0)Operating income, Q3 FY2023, three months to 2023-09-30−$35.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123506.Report this figure(28.5)Operating income, Q4 FY2023, three months to 2023-12-31−$28.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-28, accession 0000950170-25-046217. Derived: 12-month figure less the 9-month figure.Report this figure(24.5)Operating income, Q1 FY2024, three months to 2024-03-31−$24.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure(22.0)Operating income, Q2 FY2024, three months to 2024-06-30−$22.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105220.Report this figure(11.3)Operating income, Q3 FY2024, three months to 2024-09-30−$11.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure(16.2)Operating income, Q4 FY2024, three months to 2024-12-31−$16.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134499. Derived: 12-month figure less the 9-month figure.Report this figure(17.6)Operating income, Q1 FY2025, three months to 2025-03-31−$17.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure(18.6)Operating income, Q2 FY2025, three months to 2025-06-30−$18.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure(13.8)Operating income, Q3 FY2025, three months to 2025-09-30−$13.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure(9.3)Operating income, Q4 FY2025, three months to 2025-12-31−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134499. Derived: 12-month figure less the 9-month figure.Report this figure(9.3)Operating income, Q1 FY2026, three months to 2026-03-31−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure0.2Operating income, Q2 FY2026, three months to 2026-06-30$227.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(33.3)Net income, Q3 FY2023, three months to 2023-09-30−$33.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123506.Report this figure(26.9)Net income, Q4 FY2023, three months to 2023-12-31−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-28, accession 0000950170-25-046217. Derived: 12-month figure less the 9-month figure.Report this figure(23.2)Net income, Q1 FY2024, three months to 2024-03-31−$23.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure(21.1)Net income, Q2 FY2024, three months to 2024-06-30−$21.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105220.Report this figure(10.6)Net income, Q3 FY2024, three months to 2024-09-30−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure(14.9)Net income, Q4 FY2024, three months to 2024-12-31−$14.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134499. Derived: 12-month figure less the 9-month figure.Report this figure(15.3)Net income, Q1 FY2025, three months to 2025-03-31−$15.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure(18.7)Net income, Q2 FY2025, three months to 2025-06-30−$18.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure(15.8)Net income, Q3 FY2025, three months to 2025-09-30−$15.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure(9.8)Net income, Q4 FY2025, three months to 2025-12-31−$9.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134499. Derived: 12-month figure less the 9-month figure.Report this figure(6.3)Net income, Q1 FY2026, three months to 2026-03-31−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure0.5Net income, Q2 FY2026, three months to 2026-06-30$452.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure
Diluted EPS$ per share(0.70)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123506.Report this figurenot reported(0.48)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure(0.44)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105220.Report this figure(0.22)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figurenot reported(13.16)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$13.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure(15.99)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$15.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure(0.27)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figurenot reported(4.22)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$4.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure0.27Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure
Basic EPS$ per share(0.70)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123506.Report this figurenot reported(0.48)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure(0.44)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105220.Report this figure(0.22)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figurenot reported(13.16)Basic EPS, Q1 FY2025, three months to 2025-03-31−$13.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure(15.99)Basic EPS, Q2 FY2025, three months to 2025-06-30−$15.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure(0.27)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figurenot reported(4.22)Basic EPS, Q1 FY2026, three months to 2026-03-31−$4.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure0.27Basic EPS, Q2 FY2026, three months to 2026-06-30$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure

Balance sheet

Cash and equivalents$1.5m, Q2 FY2026
Shareholders' equity−$36.2m, Q2 FY2026
BioAtla, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m141Cash and equivalents, Q3 FY2023, at 2023-09-30$141.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0000950170-23-060389.Report this figure111Cash and equivalents, FY2023, at 2023-12-31$111.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-28, accession 0000950170-25-046217.Report this figure80.6Cash and equivalents, Q1 FY2024, at 2024-03-31$80.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0000950170-24-059757.Report this figure61.7Cash and equivalents, Q2 FY2024, at 2024-06-30$61.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-094164.Report this figure56.5Cash and equivalents, Q3 FY2024, at 2024-09-30$56.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123506.Report this figure49.0Cash and equivalents, FY2024, at 2024-12-31$49.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001193125-26-134499.Report this figure32.4Cash and equivalents, Q1 FY2025, at 2025-03-31$32.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure18.2Cash and equivalents, Q2 FY2025, at 2025-06-30$18.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105220.Report this figure8.3Cash and equivalents, Q3 FY2025, at 2025-09-30$8.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure7.1Cash and equivalents, FY2025, at 2025-12-31$7.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure2.0Cash and equivalents, Q1 FY2026, at 2026-03-31$2.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure1.5Cash and equivalents, Q2 FY2026, at 2026-06-30$1.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure
Current assets$m148Current assets, Q3 FY2023, at 2023-09-30$147.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060389.Report this figure116Current assets, FY2023, at 2023-12-31$116.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-28, accession 0000950170-25-046217.Report this figure86.4Current assets, Q1 FY2024, at 2024-03-31$86.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059757.Report this figure66.5Current assets, Q2 FY2024, at 2024-06-30$66.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094164.Report this figure60.6Current assets, Q3 FY2024, at 2024-09-30$60.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123506.Report this figure51.2Current assets, FY2024, at 2024-12-31$51.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001193125-26-134499.Report this figure37.5Current assets, Q1 FY2025, at 2025-03-31$37.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure20.6Current assets, Q2 FY2025, at 2025-06-30$20.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105220.Report this figure9.7Current assets, Q3 FY2025, at 2025-09-30$9.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure8.0Current assets, FY2025, at 2025-12-31$8.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure3.1Current assets, Q1 FY2026, at 2026-03-31$3.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure4.3Current assets, Q2 FY2026, at 2026-06-30$4.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure
Total assets$m151Total assets, Q3 FY2023, at 2023-09-30$151.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0000950170-23-060389.Report this figure120Total assets, FY2023, at 2023-12-31$119.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-28, accession 0000950170-25-046217.Report this figure89.2Total assets, Q1 FY2024, at 2024-03-31$89.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059757.Report this figure68.6Total assets, Q2 FY2024, at 2024-06-30$68.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-094164.Report this figure62.2Total assets, Q3 FY2024, at 2024-09-30$62.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123506.Report this figure52.4Total assets, FY2024, at 2024-12-31$52.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001193125-26-134499.Report this figure38.3Total assets, Q1 FY2025, at 2025-03-31$38.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure27.1Total assets, Q2 FY2025, at 2025-06-30$27.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105220.Report this figure15.9Total assets, Q3 FY2025, at 2025-09-30$15.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure13.8Total assets, FY2025, at 2025-12-31$13.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure8.6Total assets, Q1 FY2026, at 2026-03-31$8.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure9.5Total assets, Q2 FY2026, at 2026-06-30$9.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure
Current liabilities$m35.6Current liabilities, Q3 FY2023, at 2023-09-30$35.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060389.Report this figure28.3Current liabilities, FY2023, at 2023-12-31$28.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-28, accession 0000950170-25-046217.Report this figure19.3Current liabilities, Q1 FY2024, at 2024-03-31$19.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059757.Report this figure17.5Current liabilities, Q2 FY2024, at 2024-06-30$17.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094164.Report this figure19.5Current liabilities, Q3 FY2024, at 2024-09-30$19.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123506.Report this figure14.5Current liabilities, FY2024, at 2024-12-31$14.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001193125-26-134499.Report this figure16.0Current liabilities, Q1 FY2025, at 2025-03-31$16.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure16.6Current liabilities, Q2 FY2025, at 2025-06-30$16.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105220.Report this figure18.0Current liabilities, Q3 FY2025, at 2025-09-30$18.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure21.9Current liabilities, FY2025, at 2025-12-31$21.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure20.7Current liabilities, Q1 FY2026, at 2026-03-31$20.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure21.0Current liabilities, Q2 FY2026, at 2026-06-30$21.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure
Total liabilities$m56.7Total liabilities, Q3 FY2023, at 2023-09-30$56.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0000950170-23-060389.Report this figure49.0Total liabilities, FY2023, at 2023-12-31$49.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-28, accession 0000950170-25-046217.Report this figure39.5Total liabilities, Q1 FY2024, at 2024-03-31$39.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059757.Report this figure37.3Total liabilities, Q2 FY2024, at 2024-06-30$37.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-094164.Report this figure39.3Total liabilities, Q3 FY2024, at 2024-09-30$39.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123506.Report this figure38.2Total liabilities, FY2024, at 2024-12-31$38.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001193125-26-134499.Report this figure37.7Total liabilities, Q1 FY2025, at 2025-03-31$37.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure43.9Total liabilities, Q2 FY2025, at 2025-06-30$43.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105220.Report this figure47.1Total liabilities, Q3 FY2025, at 2025-09-30$47.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure50.0Total liabilities, FY2025, at 2025-12-31$50.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure45.9Total liabilities, Q1 FY2026, at 2026-03-31$45.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure45.7Total liabilities, Q2 FY2026, at 2026-06-30$45.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure
Shareholders' equity$m94.7Shareholders' equity, Q3 FY2023, at 2023-09-30$94.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-07, accession 0000950170-23-060389.Report this figure70.7Shareholders' equity, FY2023, at 2023-12-31$70.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-28, accession 0000950170-25-046217.Report this figure49.7Shareholders' equity, Q1 FY2024, at 2024-03-31$49.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-14, accession 0000950170-24-059757.Report this figure31.4Shareholders' equity, Q2 FY2024, at 2024-06-30$31.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-08, accession 0000950170-24-094164.Report this figure23.0Shareholders' equity, Q3 FY2024, at 2024-09-30$23.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123506.Report this figure14.3Shareholders' equity, FY2024, at 2024-12-31$14.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001193125-26-134499.Report this figure0.5Shareholders' equity, Q1 FY2025, at 2025-03-31$547.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure(16.7)Shareholders' equity, Q2 FY2025, at 2025-06-30−$16.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0000950170-25-105220.Report this figure(31.2)Shareholders' equity, Q3 FY2025, at 2025-09-30−$31.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure(36.2)Shareholders' equity, FY2025, at 2025-12-31−$36.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure(37.3)Shareholders' equity, Q1 FY2026, at 2026-03-31−$37.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure(36.2)Shareholders' equity, Q2 FY2026, at 2026-06-30−$36.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure

Cash flow

Operating cash flow−$419.0k, Q2 FY2026
BioAtla, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(27.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$27.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123506. Derived: 9-month figure less the 6-month figure.Report this figure(29.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$29.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-28, accession 0000950170-25-046217. Derived: 12-month figure less the 9-month figure.Report this figure(30.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$30.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure(19.2)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$19.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105220. Derived: 6-month figure less the 3-month figure.Report this figure(5.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-280435. Derived: 9-month figure less the 6-month figure.Report this figure(16.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134499. Derived: 12-month figure less the 9-month figure.Report this figure(16.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$16.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure(14.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$14.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349542. Derived: 6-month figure less the 3-month figure.Report this figure(9.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-280435. Derived: 9-month figure less the 6-month figure.Report this figure(7.9)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$7.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134499. Derived: 12-month figure less the 9-month figure.Report this figure(5.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure(0.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$419.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349542. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)1.66m, Q2 FY2026
BioAtla, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares37.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3037,516,769 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0000950170-23-060389.Report this figure47.6Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3147,578,418 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059757.Report this figure47.7Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3047,706,426 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-094164.Report this figure47.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3047,834,122 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123506.Report this figure48.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3148,087,460 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000950170-25-064594.Report this figure48.2Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3048,214,893 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105220.Report this figure48.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3048,335,847 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure1.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-311,164,984 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure1.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-301,170,087 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure58.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3058,745,343 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-280435.Report this figure1.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-311,501,649 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001193125-26-226631.Report this figure1.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-301,661,709 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349542.Report this figure

Shares outstanding: 32.32mShares outstanding, period not labelled, at 2021-08-1332,315,301 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2021-08-13, accession 0000950170-21-001443.Report this figure at Aug 13, 2021, from the cover of the 10-Q filed Aug 13, 2021.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.